Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells

Cancer Research

Volumn 65, Issue 6, 2005, Pages 2193-2198

  Jay, Philippe ^a   Berta, Philippe ^a   Blache, Philippe ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HT29 CELLS; HUMANS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 16844375712     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1484     Document Type: Article

References (25)

1. Hammarstrom S, Baranov V. Is there a role for CEA in innate immunity inthe colon? Trends Microbiol 2001;9:119-25.
2. Abbasi AM, Chester KA, MacPherson AJ, Boxer GM, Begent RH, Malcolm AD. Localization of CEA messenger RNA by in situ hybridization in normal colonic mucosa and colorectal adenocarcinomas. J Pathol 1992;168:405-11.
3. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34.
4. Ilantzis C, Jothy S, Alpert LC, Draber P, Stanners CP. Cell-surface levels of human Carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. Lab Invest 1997;76:703-16.
5. Yan Z, Deng X, Chen M, et al. Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells. J Biol Chem 1997;272:27902-7.
6. Wirth T, Soeth E, Czubayko F, Juhl H. Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin Exp Metastasis 2002;19:155-60.
7. Ordonez C, Screaton RA, Ilantzis C, Stanners CP. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 2000;60:3419-24.
8. Ueda K, Iwahashi M, Nakamori M, et al. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer. Surgery 2003;133:309-17.
9. Horig H, Medina FA, Conkright WA, Kaufman HL. Strategies for cancer therapy using carcinoembryonic antigen vaccines. Expert Rev Mol Med 2000;2000:1-24.
10. Blache P, Van De Wetering M, Duluc I, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004;166:37-47.
11. De Santa Barbara P, Bonneaud N, Boizet B, et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene. Mol Cell Biol 1998;18:6653-65.
12. Sudbeck P, Schmitz ML, Baeuerle PA, Scherer G. Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat Genet 1996;13:230-2.
13. Schrewe H, Thompson J, Bona M, et al. Cloning of the complete gene for carcinoembryonic antigen: analysis of its promoter indicates a region conveying cell type-specific expression. Mol Cell Biol 1990;10:2738-48.
14. Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2000;16:182-7.
15. Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, Augenlicht L. Patterns of expression of lineage-specific markers during the in vitro induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ 1995;6:749-57.
16. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoprosis in human colonic carcinoma cell lines. Cancer Res 1994;54:3288-93.
17. Augenlicht L, Shi L, Mariadason J, Laboisse C, Velcich A. Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. Oncogene 2003;22:4983-92.
18. Mariadason JM, Bordonaro M, Aslam F, et al. Down-regulation of β-catenin TCF signaling is linked to colonic epithelial cell differentiation. Cancer Res 2001;61:3465-71.
19. Hauck W, Stanners CP. Transcriptional regulation of the carcinoembryonic antigen gene. Identification of regulatory elements and multiple nuclear factors. J Biol Chem 1995;270:3602-10.
20. Mertin S, McDowall SG, Harley VR. The DMA-binding specificity of SOX9 and other SOX proteins. Nucleic Acids Res 1999;27:1359-64.
21. Ng LJ, Wheatley S, Muscat GE, et al. SOX9 binds DNA, activates transcription, and coexpresses with type 11 collagen during chondrogenesis in the mouse. Dev Biol 1997;183:108-21.
22. Lee YH, Aoki Y, Hong CS, Saint-Germain N, Credidio C, Saint-Jeannet JP. Early requirement of the transcriptional activator Sox9 for neural crest specification in Xenopus. Dev Biol 2004;275:93-103.
23. Vogel I, Francksen H, Soeth E, Henne-Bruns D, Kremer B, Juhl H. The carcinoembryonic antigen and its prognostic impact on immunocytologically detected intraperitoneal colorectal cancer cells. Am J Surg 2001;181:188-93.
24. Soeth E, Wirth T, List HJ, et al. Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res 2001;7:2022-30.
25. Ilantzis C, DeMarte L, Screaton RA, Stanners CP. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 2002;4:151-63.